IN201841029923A - - Google Patents

Download PDF

Info

Publication number
IN201841029923A
IN201841029923A IN201841029923A IN201841029923A IN201841029923A IN 201841029923 A IN201841029923 A IN 201841029923A IN 201841029923 A IN201841029923 A IN 201841029923A IN 201841029923 A IN201841029923 A IN 201841029923A IN 201841029923 A IN201841029923 A IN 201841029923A
Authority
IN
India
Application number
IN201841029923A
Other languages
English (en)
Original Assignee
Gland Pharma Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gland Pharma Ltd filed Critical Gland Pharma Ltd
Priority to IN201841029923A priority Critical patent/IN201841029923A/en
Publication of IN201841029923A publication Critical patent/IN201841029923A/en

Links

IN201841029923A 2018-08-09 2018-08-09 IN201841029923A (https=)

Priority Applications (1)

Application Number Priority Date Filing Date Title
IN201841029923A IN201841029923A (https=) 2018-08-09 2018-08-09

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IN201841029923A IN201841029923A (https=) 2018-08-09 2018-08-09

Publications (1)

Publication Number Publication Date
IN201841029923A true IN201841029923A (https=) 2020-02-14

Family

ID=92830878

Family Applications (1)

Application Number Title Priority Date Filing Date
IN201841029923A IN201841029923A (https=) 2018-08-09 2018-08-09

Country Status (1)

Country Link
IN (1) IN201841029923A (https=)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP4146664A4 (en) * 2020-05-01 2024-11-13 Ripple Therapeutics Corporation HETERODIMER COMPOSITIONS AND METHODS FOR TREATING OCULAR DISEASES
US12509469B2 (en) 2019-08-07 2025-12-30 Ripple Therapeutics Corporation Compositions and methods for the treatment of pain and dependence disorders

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US12509469B2 (en) 2019-08-07 2025-12-30 Ripple Therapeutics Corporation Compositions and methods for the treatment of pain and dependence disorders
EP4146664A4 (en) * 2020-05-01 2024-11-13 Ripple Therapeutics Corporation HETERODIMER COMPOSITIONS AND METHODS FOR TREATING OCULAR DISEASES

Similar Documents

Publication Publication Date Title
BR112021012222A2 (https=)
BR112021008873A2 (https=)
BR122022006221A2 (https=)
BR112021000792B8 (https=)
BR122022015534A2 (https=)
BR122022002096A2 (https=)
AT524834A2 (https=)
AT524874A5 (https=)
AU2018438767B1 (https=)
IN201841029923A (https=)
AT524961A5 (https=)
BR122022005529A2 (https=)
BR122022016585A2 (https=)
BR112020012832A2 (https=)
BR102018070765A2 (https=)
BR102018016915A2 (https=)
BE2018C025I2 (https=)
BR112020025288A2 (https=)
BR202018008879U2 (https=)
BR202018007669U2 (https=)
BR102018007062A2 (https=)
BR202018006247U2 (https=)
BR202018004136U2 (https=)
BR202018002487U2 (https=)
BR202018002069U2 (https=)